The AI Director sits within DP&I (Development Operations Platforms & Innovation), part of Development Global Clinical Operations at GSK. DP&I builds and deploys scalable, AI-native capabilities, shared foundations, and new ways of working across Development Operations, working with clinical operations, technology, product, data, and external partners. The role drives GSK’s AI-native Development Operations strategy: identifying where AI can create meaningful value, building and testing concepts with frontier tools, and shaping priority capabilities from concept through scaled deployment. The AI Director partners with business subject-matter experts and enterprise technology teams to prototype, pressure-test, and deploy AI-enabled workflows. The role also leads vendor evaluation and shapes build-buy-partner decisions when external capabilities are needed, applying structured problem-solving, commercial judgement, enterprise credibility, and hands-on fluency with frontier agentic development tools. It reports to the Head of Asset Acceleration and AI. The position aims to help measurably accelerate clinical trial delivery and improve outcomes for patients. It covers strategy and opportunity prioritisation, external landscape assessment, business cases and stage-gate decisions, deployment strategy and solution architecture, cross-functional alignment, hands-on incubation and prototyping, and adoption planning for scaled AI-native capabilities.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Director